SYNGENE INTERNATIONAL LIMITED UNIT VII POD 3.

Company Introduction:

Syngene International Limited is a leading integrated research, development, and manufacturing organization (CRDMO) based in India. The company offers comprehensive discovery, development, and manufacturing services for small molecules, large molecules, and oligonucleotides. Syngene serves a global clientele across various sectors including pharmaceutical, biotechnology, nutrition, animal health, and consumer goods. It is known for its scientific expertise, state-of-the-art infrastructure, and adherence to global quality standards. "UNIT VII POD 3" refers to a specific operational facility or section within Syngene's extensive network of research and manufacturing sites, typically located in Bengaluru, India, where much of their core operations are concentrated. This unit contributes to the company's overall capacity for scientific research, process development, and manufacturing.

Factory or Trader:

SYNGENE INTERNATIONAL LIMITED UNIT VII POD 3 is a factory. It is an integral part of Syngene's manufacturing and research and development infrastructure, involved in the actual production, synthesis, and processing of compounds and biologicals, as well as conducting scientific research and development activities. It is not a trading entity.

Syngene International Limited is a leading contract research, development, and manufacturing organization (CRDMO). The company produces or sells a comprehensive range of scientific services to pharmaceutical, biotechnology, nutrition, animal health, and specialty chemical companies worldwide. These services include:

Discovery services: encompassing target identification and validation, hit generation, lead optimization, and medicinal chemistry.

Development services: covering process research and development, analytical method development, formulation development, and pre-clinical and clinical development support.

Manufacturing services: including the production of active pharmaceutical ingredients (APIs), intermediates, and drug products for clinical trials and commercial supply.

Biology services: focused on in vitro and in vivo biology, toxicology, and pharmacology.

Chemistry services: spanning synthetic chemistry, process chemistry, and analytical chemistry.

Biologics services: for the discovery, development, and manufacturing of biologics such as monoclonal antibodies and other proteins.